Last week was magnificent. Our tech stocks have done, on balance, very well — for reasons I somewhat understand. Most have nice growth and oodles of buzz. Take some money home. Buy yourself a new Tesla. I bought some more DOCS, whose real name is Doximity. It describes itself as: The professional medical network for […]